Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
World Journal of Hepatology|August 18, 2022
Fibrosis regression following hepatitis C antiviral therapyAisha Elsharkawy, Reham Samir, Mohamed El-KassasInfection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|April 4, 2017
miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinomaOlfat Shaker, Maha Alhelf, George Morcos, et al.Hepatic Medicine : Evidence and Research|May 30, 2017
Hepatitis C infection in Egypt: prevalence, impact and management strategiesAsmaa Gomaa, Naglaa Allam, Aisha Elsharkawy, et al.Expert Review of Anti-Infective Therapy|March 7, 2018
HCV in Egypt, prevention, treatment and key barriers to eliminationMohamed El Kassas, Tamer Elbaz, Aisha Elsharkawy, et al.Expert Review of Anti-Infective Therapy|April 18, 2020
Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from EgyptGamal Esmat, Tamer Elbaz, Aisha Elsharkawy, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 5, 2014
Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns' index in chronic hepatitis C virusMohamed Alboraie, Marwa Khairy, Marwa Elsharkawy, et al.BMC Infectious Diseases|July 9, 2024
Prevalence of vitamin D deficiency and the effect of vitamin D3 supplementation on response to anti-tuberculosis therapy in patients with extrapulmonary tuberculosisRasha Eletreby, Aisha Elsharkawy, Rahma Mohamed, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|December 1, 2021
Current status of hepatitis C virus among people living with human immunodeficiency virus in EgyptAisha Elsharkawy, Shereen Abdel Alem, Ahmed Cordie, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 23, 2018
Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing RegimensMaissa El-Raziky, Marwa Khairy, Ahmed Fouad, et al.Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|May 7, 2025
Changes in liver stiffness and non-invasive markers in chronic hepatitis C virus patients with and without HIV co-infection following interferon-free antiviral treatmentShereen Abdel Alem, Zeinab Abdellatif, Rahma Mohamed, et al.Pageof 6